We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
XOBET CREAM/ DPL-CLOBETASOL CREAM/ CLOXOBET CREAM/ XOBET OINTMENT/ DPL-CLOBETASOL OINTMENT/ CLOXOBET OINTMENT (Douglas Pharmaceuticals Australia Pty Ltd)
Product name
XOBET CREAM/ DPL-CLOBETASOL CREAM/ CLOXOBET CREAM/ XOBET OINTMENT/ DPL-CLOBETASOL OINTMENT/ CLOXOBET OINTMENT
Date registered
Evaluation commenced
Decision date
Approval time
217 (255 working days)
Active ingredients
Clobetasol propionate
Registration type
EOI
Indication
Short-term treatment of resistant or severe inflammatory and pruritic manifestations of steroid responsive dermatoses, including psoriasis (excluding widespread plaque psoriasis), recalcitrant dermatoses, lichen sclerosus/planus and discoid lupus erythematosus in adults.